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October 20111230 AbstractsConclusions:Quantifiable and reproducible radiation scatter is created
during interventional procedures. Radiation doses vary widely around the
perimeter of the angiography table andmay be referred to as “scatter cloud.”
This “scatter cloud” differs from the levels predicted by the inverse square
law. Knowledge of the actual exposure levels within the endovascular
environment may help in mitigating these risks.
Comparative Analysis of Endarterectomy and Stenting For the Treat-
ment of Carotid Stenosis in Women
Ageliki Vouyouka, Natalia Egorova, Alan Moskowitz, Annetine Gelijns, Mi-
chael Marin, Peter Faries, Mount Sinai School of Medicine, New York, NY
Introduction and objectives: Although large randomized studies
have established the efficacy and safety of carotid endarterectomy (CEA) and
stenting (CAS), the under-representation of women leaves the comparison
of risks to benefits of performing these procedures on women an open
question. To address this issue, we delineated patient characteristics predict-
ing outcomes in women undergoing carotid interventions.
Methods:We analyzed in-hospital mortality, postoperative stroke, and
the composite end points of stoke or death in 20,620 hospitalizations in
New York and Florida for 2007 to 2009. Univariate and multivariable
logistic regression analyses were performed.
Results: CEAs were performed in 16,576 asymptomatic and in 1744
symptomatic women and CAS in 1948 asymptomatic and in 352 symptom-
atic women. Compared with CAS, CEA rates were significantly lower for
in-hospital mortality, stroke, and combined stroke/mortality (Table). Car-
diac complication rates did not differ among asymptomatic women, but
cardiac complications were more frequent among symptomatic women with
CAS (10.5% vs 6.5%, P .008). Among symptomatic women, the presence
of renal disease, CAD, or age80 years increased the risk of CAS over CEA
threefold for the composite end point of stroke or death. For asymptomatic
women, only in those with CAD or diabetes, there was a significant differ-
ence in the mortality/stroke rates favoring CEA. After adjusting for relevant
clinical and demographic risk factors, CAS increased the risk for the com-
posite end point of stoke or death in both symptomatic and asymptomatic
patients.
Conclusions: These databases reflect real-world practice performance
of the management of carotid disease in women and suggest that CEA has
better perioperative outcomes in women. Importantly, CAS is associated
with significant morbidity in certain clinical settings, and this should be
taken into account when choosing a revascularization procedure.
In-hospital outcomes after carotid endarterectomy (CEA) and carotid
artery stenting (CAS) in asymptomatic and symptomatic women
Table.
Outcome
Asymptomatic Symptomatic
CEA, % CAS, % P CEA, % CAS, % P
Mortality 0.3 0.8 .0007 0.4 3.4 .0001
Post-op
stroke
1.5 2.6 .0004 3.5 9.7 .0001
Stroke/
mortality
1.7 3.1 .0001 3.8 11.1 .0001
Comparison of Carotid Endarterectomy and Stenting in Real-World
Practice Using a Regional Quality-Improvement Registry
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of Massachusetts Memorial Medical Center, Worcester, Mass; 4Massachu-
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Introduction and objectives: Carotid artery stenting (CAS) remains
controversial despite recent randomized controlled trials. This study com-
pared the outcomes of CAS and carotid endarterectomy (CEA) in real-world
practice.
Methods: This was a retrospective analysis of 7649 CEA and 430 CAS
procedures performed at 17 centers from 2003 to 2010 within the Vascular Study
Group of New England. Two primary outcomemeasures were (1) any in-hospital
stroke or death, and (2) any stroke, death, permanent cranial nerve injury (CNI), or
myocardial infarction (MI). Combined coronary artery bypass grafting and CEA
procedures were excluded. Multivariate analysis was performed to identify predic-
tors of in-hospital stroke/death in patients undergoing CAS.
Results: Patients undergoing CAS had increased prevalence of coronary
artery disease, congestive heart failure, diabetes mellitus, and prior ipsilateral
CEA. CAS was performed in six centers by 30 surgeons and 8 interventionalists
with a case volume per operator ranging from1 to 137. Embolic protectionwas
used in 97% of CAS. Shunts were used in 48% of CEA. The overall in-hospital
C
vtroke/death rate was higher amongpatients undergoingCAS (2.3% vs 1.1%,P
028), which was due to an increased risk of stroke/death in symptomatic
atients. Asymptomatic patients had similar rates of stroke/death with CEA
nd CAS. Overall rates of stroke, death, MI, and CNI were not different
etween CEA and CAS. Cortical symptoms (odds ratio [OR]; 7.3; 95%
onfidence interval [CI], 1.8-29.3), age 70 years (OR, 5.3; 95% CI,
.1-26.3), and CHF (OR, 3.9; 95% CI, 1.0-15.0) were predictors of
troke/death in patients undergoing CAS (Table).
able. Outcomes of carotid endarterectomy (CEA) and
arotid artery stenting (CAS) within the ascular Study
roup of New England
Variable No.
Overall
(n  8,079), %
Asymptomatic
(n  5,316), %
Symptomatic
(n  2,761), %
Stroke,
death
Stroke,
death,
CNI, MI
Stroke,
death
Stroke,
death,
CNI, MI
Stroke,
death
Stroke,
death,
CNI,
MI
CEA 7649 1.1 4.1 0.89 3.6 1.6 5.0
CAS 430 2.3 2.8 0.73 1.1 5.1 5.8
P .028 0.183 .784 .027 .001 .654
NI, Cranial nerve injury; myocardial infarction;MI,myocardial infarction.
Conclusions: In our regional vascular registry, CAS is performed in
atients at high operative risk. The overall outcomes of CAS and CEA are
imilar when accounting for permanent CNI and MI. However, symptom-
tic patients treated with CAS are at higher risk stroke or death. CAS may be
est suited for asymptomatic patients.
atients Considered “High Risk” For Carotid Endarterectomy are at
ncreased Risk of Adverse Events After Carotid Artery Stenting
hunsuke Yoshida, Christoph S. Nabzdyk, Julia D. Glaser, Rodney P.
ensley, Allen D. Hamdan, Frank B. Pomposelli, Mark C. Wyers, Elliot L.
haikof, Marc L. Schermerhorn, Beth Israel Deaconess Medical Center,
oston, Mass
Introduction and objectives: Current guidelines allow stenting as an
lternative in patients considered “high risk” for carotid endarterectomy
CEA). There is conflicting evidence regarding high-risk criteria for CEA
nd the safety of stenting in these patients. Using CMS inclusion criteria for
arotid artery stenting (CAS), we stratified patients that underwent CAS or
EA by risk status and compared their outcomes.
Methods: A retrospective record review of all CAS and CEA proce-
ures from 2001 through 2010 at a tertiary medical center was performed.
atients were identified using International Classification of Diseases, 9th
evision, Clinical Modification codes and stratified according to Centers for
edicare and Medicaid Services high-risk status and adjusted for symptom
tatus. We compared differences in outcomes among each subgroup of
atients that underwent CAS or CEA. Multivariable logistic regression was
sed to determine predictors of death alone or combined 30-day adverse
vents of cerebrovascular accident (CVA) or transient ischemic attack (TIA),
yocardial infarction (MI), or death.
Results: We identified 307 CAS patients (61.9% high-risk) and 1018 CEA
atients (25.8% high-risk). Complications occurred in 18 of 190 high-risk CAS
atients (9.5%), including 9 CVAs (4.7%), 4 TIAs (2.1%), 3 MIs (1.6%), and 4
eaths (2.1%).Complicationsoccurred in14of 263high-riskCEApatients (5.3%),
ncluding10CVAs (3.8%), 3TIAs (1.1%), 1MI (0.4%), and1death (0.4%;Table).
hysiologic high-risk status predicted adverse events after CAS (odds ratio [OR]
.54; 95% confidence interval [CI], 1.01-6.42; P .047) but not after CEA (OR,
.89; 95% CI, 0.59-2.16; P  .36). Controlling for physiologic high-risk and
ymptomstatus revealedCAShad an increased risk of deathoverCEA(OR,10.13;
5% CI, 1.07-95.61; P .04).
able.
Variable No.
Symptomatic
(%)
CVA
(%)
TIA
(%)
Death
(%)
MI
(%)
Combined
(%)
CAS risk
High 190 35.2 4.7 2.1 2.1 1.6 9.5
Low 117 24.8 0.0 3.4 0.0 0.0 4.3
CEA risk
High 263 41.4 3.8 1.1 0.4 0.4 5.3
Low 755 36.7 2.8 1.2 0.0 1.1 5.1AS, Carotid artery stenting; CEA, carotid endarterectomy; CVA, cerebro-
ascular accident;MI,myocardial infarction; TIA, transient ischemic attack.
